Page last updated: 2024-09-05

trimix and Melanoma

trimix has been researched along with Melanoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benteyn, D; Bonehill, A; Corthals, J; Heirman, C; Neyns, B; Thielemans, K; Van Nuffel, AM; Wilgenhof, S	1

Trials

1 trial(s) available for trimix and Melanoma

Article	Year
Intravenous and intradermal TriMix-dendritic cell therapy results in a broad T-cell response and durable tumor response in a chemorefractory stage IV-M1c melanoma patient. Cancer immunology, immunotherapy : CII, 2012, Volume: 61, Issue:7 Topics: Amino Acid Sequence; CD27 Ligand; CD40 Ligand; Dendritic Cells; Electroporation; Helium; Humans; Hypersensitivity, Delayed; Immunotherapy, Adoptive; Male; Melanoma; Middle Aged; Molecular Sequence Data; Neoplasm Staging; Nitrogen; Oxygen; Prospective Studies; RNA, Messenger; T-Lymphocytes; Toll-Like Receptor 4	2012

Article

Year

Intravenous and intradermal TriMix-dendritic cell therapy results in a broad T-cell response and durable tumor response in a chemorefractory stage IV-M1c melanoma patient.

Cancer immunology, immunotherapy : CII, 2012, Volume: 61, Issue:7

Topics: Amino Acid Sequence; CD27 Ligand; CD40 Ligand; Dendritic Cells; Electroporation; Helium; Humans; Hypersensitivity, Delayed; Immunotherapy, Adoptive; Male; Melanoma; Middle Aged; Molecular Sequence Data; Neoplasm Staging; Nitrogen; Oxygen; Prospective Studies; RNA, Messenger; T-Lymphocytes; Toll-Like Receptor 4

2012